Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Depot Contraception With and Without Lopinavir/Ritonavir
This study has been withdrawn prior to enrollment.
( Ethics board said the study could not be fully justified. )
Study NCT01231451 Information provided by St Stephens Aids Trust
First Received on October 29, 2010. Last Updated on November 25, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infection
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
DMPA
Additional drug interventions recognized in this trial
Lopinavir
Medroxyprogesterone
Medroxyprogesterone Acetate
Ritonavir
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antiviral Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Enzyme Inhibitors
HIV Protease Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
St Stephens Aids Trust
Back to top of Main Content
